230 related articles for article (PubMed ID: 9873534)
1. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library.
Carroll CD; Patel H; Johnson TO; Guo T; Orlowski M; He ZM; Cavallaro CL; Guo J; Oksman A; Gluzman IY; Connelly J; Chelsky D; Goldberg DE; Dolle RE
Bioorg Med Chem Lett; 1998 Sep; 8(17):2315-20. PubMed ID: 9873534
[TBL] [Abstract][Full Text] [Related]
2. Additional interaction of allophenylnorstatine-containing tripeptidomimetics with malarial aspartic protease plasmepsin II.
Hidaka K; Kimura T; Tsuchiya Y; Kamiya M; Ruben AJ; Freire E; Hayashi Y; Kiso Y
Bioorg Med Chem Lett; 2007 Jun; 17(11):3048-52. PubMed ID: 17400453
[TBL] [Abstract][Full Text] [Related]
3. Plasmepsin II inhibition and antiplasmodial activity of Primaquine-Statine 'double-drugs'.
Romeo S; Dell'Agli M; Parapini S; Rizzi L; Galli G; Mondani M; Sparatore A; Taramelli D; Bosisio E
Bioorg Med Chem Lett; 2004 Jun; 14(11):2931-4. PubMed ID: 15125962
[TBL] [Abstract][Full Text] [Related]
4. New inhibitors of the malaria aspartyl proteases plasmepsin I and II.
Dahlgren A; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2003 Aug; 11(16):3423-37. PubMed ID: 12878137
[TBL] [Abstract][Full Text] [Related]
5. Enhanced antimalarial activity of plasmepsin V inhibitors by modification of the P
Nguyen W; Hodder AN; de Lezongard RB; Czabotar PE; Jarman KE; O'Neill MT; Thompson JK; Jousset Sabroux H; Cowman AF; Boddey JA; Sleebs BE
Eur J Med Chem; 2018 Jun; 154():182-198. PubMed ID: 29800827
[TBL] [Abstract][Full Text] [Related]
6. New potent C2-symmetric malaria plasmepsin I and II inhibitors.
Oscarsson K; Oscarson S; Vrang L; Hamelink E; Hallberg A; Samuelsson B
Bioorg Med Chem; 2003 Apr; 11(7):1235-46. PubMed ID: 12628651
[TBL] [Abstract][Full Text] [Related]
7. Solid-phase library synthesis of reversed-statine type inhibitors of the malarial aspartyl proteases plasmepsin I and II.
Dahlgren A; Kvarnström I; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
Bioorg Med Chem; 2003 Mar; 11(6):827-41. PubMed ID: 12614868
[TBL] [Abstract][Full Text] [Related]
8. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.
Silva AM; Lee AY; Gulnik SV; Maier P; Collins J; Bhat TN; Collins PJ; Cachau RE; Luker KE; Gluzman IY; Francis SE; Oksman A; Goldberg DE; Erickson JW
Proc Natl Acad Sci U S A; 1996 Sep; 93(19):10034-9. PubMed ID: 8816746
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a structure-based statine cyclic diamino amide encoded combinatorial library against plasmepsin II and cathepsin D.
Carroll CD; Johnson TO; Tao S; Lauri G; Orlowski M; Gluzman IY; Goldberg DE; Dolle RE
Bioorg Med Chem Lett; 1998 Nov; 8(22):3203-6. PubMed ID: 9873703
[TBL] [Abstract][Full Text] [Related]
10. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
Zürcher M; Gottschalk T; Meyer S; Bur D; Diederich F
ChemMedChem; 2008 Feb; 3(2):237-40. PubMed ID: 17918177
[No Abstract] [Full Text] [Related]
11. Design of new plasmepsin inhibitors: a virtual high throughput screening approach on the EGEE grid.
Kasam V; Zimmermann M; Maass A; Schwichtenberg H; Wolf A; Jacq N; Breton V; Hofmann-Apitius M
J Chem Inf Model; 2007; 47(5):1818-28. PubMed ID: 17727268
[TBL] [Abstract][Full Text] [Related]
12. Click Inspired Synthesis of Novel Cinchonidine Glycoconjugates as Promising Plasmepsin Inhibitors.
Mishra N; Agrahari AK; Bose P; Singh SK; Singh AS; Tiwari VK
Sci Rep; 2020 Feb; 10(1):3586. PubMed ID: 32108142
[TBL] [Abstract][Full Text] [Related]
13. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Hidaka K; Kimura T; Ruben AJ; Uemura T; Kamiya M; Kiso A; Okamoto T; Tsuchiya Y; Hayashi Y; Freire E; Kiso Y
Bioorg Med Chem; 2008 Dec; 16(23):10049-60. PubMed ID: 18952439
[TBL] [Abstract][Full Text] [Related]
14. Potent, low-molecular-weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II.
Haque TS; Skillman AG; Lee CE; Habashita H; Gluzman IY; Ewing TJ; Goldberg DE; Kuntz ID; Ellman JA
J Med Chem; 1999 Apr; 42(8):1428-40. PubMed ID: 10212129
[TBL] [Abstract][Full Text] [Related]
15. Structural basis for plasmepsin V inhibition that blocks export of malaria proteins to human erythrocytes.
Hodder AN; Sleebs BE; Czabotar PE; Gazdik M; Xu Y; O'Neill MT; Lopaticki S; Nebl T; Triglia T; Smith BJ; Lowes K; Boddey JA; Cowman AF
Nat Struct Mol Biol; 2015 Aug; 22(8):590-6. PubMed ID: 26214367
[TBL] [Abstract][Full Text] [Related]
16. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
[TBL] [Abstract][Full Text] [Related]
17. Design and synthesis of potent inhibitors of the malaria aspartyl proteases plasmepsin I and II. Use of solid-phase synthesis to explore novel statine motifs.
Johansson PO; Chen Y; Belfrage AK; Blackman MJ; Kvarnström I; Jansson K; Vrang L; Hamelink E; Hallberg A; Rosenquist A; Samuelsson B
J Med Chem; 2004 Jun; 47(13):3353-66. PubMed ID: 15189032
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, biological evaluation, and modeling studies of inhibitors aimed at the malarial proteases plasmepsins I and II.
Muthas D; Nöteberg D; Sabnis YA; Hamelink E; Vrang L; Samuelsson B; Karlén A; Hallberg A
Bioorg Med Chem; 2005 Sep; 13(18):5371-90. PubMed ID: 16054370
[TBL] [Abstract][Full Text] [Related]
19. Inhibitors of the Plasmodium falciparum parasite aspartic protease plasmepsin II as potential antimalarial agents.
Boss C; Richard-Bildstein S; Weller T; Fischli W; Meyer S; Binkert C
Curr Med Chem; 2003 Jun; 10(11):883-907. PubMed ID: 12678679
[TBL] [Abstract][Full Text] [Related]
20. High-speed optimization of inhibitors of the malarial proteases plasmepsin I and II.
Nöteberg D; Schaal W; Hamelink E; Vrang L; Larhed M
J Comb Chem; 2003; 5(4):456-64. PubMed ID: 12857114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
